Immatics director granted 48,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Immatics N.V. director Alise Reicin reported a compensation-related award of stock options. She received 48,000 Stock Options (Right to Buy) to acquire Immatics ordinary shares.
The options carry an exercise price of $9.09 per share, expire on June 15, 2036, and vest 100% on June 16, 2026. Following this grant, Reicin holds 48,000 derivative securities of this type directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 48,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. These Options vest 100% on the first anniversary of the grant date, June 16, 2026.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Grant, award, or other acquisition financial
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Immatics (IMTX) report for Alise Reicin?
What are the key terms of Alise Reicin’s Immatics (IMTX) stock options?
When do Alise Reicin’s Immatics (IMTX) stock options vest?
How many Immatics (IMTX) derivative securities does Alise Reicin hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.